Looking ahead to China in 2022, many wealth managers could not help but hold their breath. Between slowing global demand, rising inflation and the Omicron coronavirus variant doing its worst, the pragmatic take seems to be caution — or even reducing exposure to Asia’s largest economy. Yet three recent events could make China a surprise bright spot for private bank…
China’s pivot from zero-COVID could be a ‘buy’ signal for private banks
By William Pesek, contributing editor | 28 January 2022

iStock photo by Getty Images
Share article
Share article
Related News

China’s latest COVID lockdowns send chill through private bank portfolios
8 April 2022

Asia’s private banks cool on Chinese ADRs as de-listing threat grows
25 March 2022

From Fed tightening to Omicron in China: Risks mount for Asia’s private banks
18 March 2022

Private banks rip up 2022 playbook over Ukraine crisis
7 March 2022

Private banks spy buying opportunity after volatility hits China new energy assets
4 March 2022

Exclusive
As Hong Kong buckles under fifth COVID wave, BNP, HSBC and UBS explain philanthropic advisory services
25 February 2022

Hong Kong’s COVID-19 ‘vaccine pass’ could give private banks a headache
11 February 2022

Private banks can’t agree on whether to buy the dip in China
26 January 2022

World’s biggest trade deal to boost ASEAN assets: private banks
17 January 2022

Private banks warn of volatility as Omicron COVID-19 variant spreads
29 November 2021

Investment outlook for 2022: Private banks bet China’s regulatory crackdown is over
26 November 2021

Credit Suisse revamp quickens pivot to Asia-Pacific
5 November 2021